Literature DB >> 3297449

In vitro degradation of extracellular matrix by human ovarian carcinoma cells.

M J Niedbala, K Crickard, R J Bernacki.   

Abstract

Better in vitro models are needed to elucidate the mechanisms underlying tissue destruction by human tumor cells. To address this matter recently isolated and characterized human ovarian carcinoma cell lines derived from either primary tumors, ascitic effusions or metastatic growths were plated in direct contact with extracellular matrix (ECM) previously deposited on culture dishes by bovine corneal endothelial cells. Light and electron microscopy of four of the five ovarian tumor cell lines demonstrated morphologic digestion with penetration of ECM by tumor cell microvilli, along with associated rarefaction. The ability of these same ovarian tumor cell lines to solubilize specific carbohydrate and protein moieties present in intact ECM was assessed with the use of metabolically prelabeled ECM employing tritiated fucose, galactose, glucosamine and proline. Results from these studies corroborated morphologic observations in which four of the five tumor cell lines tested extensively solubilized radiolabeled ECM. The kinetics of radiolabel release from ECM illustrated that three of the four invasive tumors released [3H]fucose, [3H]glucosamine and [3H]proline at high rates. Normal human ovarian fibroblasts and mesothelial cells were observed to be unable to digest ECM and this was consistent with their inability to release radiolabeled material from prelabeled ECM. The results from these studies suggest that some ovarian carcinomas have the ability to degrade basement membrane components. Knowledge regarding the mechanisms responsible for tissue degradation may eventually lead to the development of new chemotherapeutic modalities designed to restrict tumor cell invasion, growth and metastasis.

Entities:  

Mesh:

Year:  1987        PMID: 3297449     DOI: 10.1007/BF00058063

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  35 in total

1.  An electron microscopic study of pulmonary tumor emboli from transplantable Morris hepatoma 5123.

Authors:  R M Ludatscher; S A Luse; V Suntzeff
Journal:  Cancer Res       Date:  1967-11       Impact factor: 12.701

2.  Carcinoma of the ovary. A clinicopathological study of 86 autopsied cases with special reference to mode of spread.

Authors:  F Bergman
Journal:  Acta Obstet Gynecol Scand       Date:  1966       Impact factor: 3.636

3.  A rapid single step staining technique for DNA analysis by flow microfluorimetry.

Authors:  I W Taylor
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

4.  Loss of basement membrane components by invasive tumors but not by their benign counterparts.

Authors:  S H Barsky; G P Siegal; F Jannotta; L A Liotta
Journal:  Lab Invest       Date:  1983-08       Impact factor: 5.662

5.  The production and localization of laminin in cultured vascular and corneal endothelial cells.

Authors:  D Gospodarowicz; G Greenburg; J M Foidart; N Savion
Journal:  J Cell Physiol       Date:  1981-05       Impact factor: 6.384

6.  Characterization of collagens synthesized by cultured bovine corneal endothelial cells.

Authors:  S C Tseng; N Savion; D Gospodarowicz; R Stern
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

7.  Degradation of the subendothelial matrix by tumor cells.

Authors:  W E Laug; Y A DeClerck; P A Jones
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

8.  Human ovarian carcinoma cells maintained on extracellular matrix versus plastic.

Authors:  K Crickard; U Crickard; M Yoonessi
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

Review 9.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

10.  Extracellular matrix-coated culture dishes: an in vitro model for primary human gynecologic tumors.

Authors:  K Crickard; U Crickard; M Yoonessi; H Caglar
Journal:  Cancer Genet Cytogenet       Date:  1986-01-01
View more
  10 in total

Review 1.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

2.  Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications.

Authors:  H S Berner; B Davidson; A Berner; B Risberg; G B Kristensen; C G Trope; G Van de Putte; J M Nesland
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Three-dimensional culture of a mixed mullerian tumor of the ovary: expression of in vivo characteristics.

Authors:  T J Goodwin; T L Prewett; G F Spaulding; J L Becker
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

4.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Pamela N Peters; Elizabeth M Schryver; Ernst Lengyel; Hilary Kenny
Journal:  J Vis Exp       Date:  2015-12-31       Impact factor: 1.355

Review 5.  Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.

Authors:  Hilary A Kenny; Songuel Dogan; Marion Zillhardt; Anirban K Mitra; S Diane Yamada; Thomas Krausz; Ernst Lengyel
Journal:  Cancer Treat Res       Date:  2009

6.  Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.

Authors:  Natalie M Moss; Maria V Barbolina; Yueying Liu; Limin Sun; Hidayatullah G Munshi; M Sharon Stack
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

Review 7.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

8.  An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis.

Authors:  Marion Zillhardt; James G Christensen; Ernst Lengyel
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715

9.  Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2.

Authors:  Yulan Liu; Ling Xi; Guoning Liao; Wei Wang; Xun Tian; Beibei Wang; Gang Chen; Zhiqiang Han; Mingfu Wu; Shixuan Wang; Jianfeng Zhou; Gang Xu; Yunping Lu; Ding Ma
Journal:  BMC Cancer       Date:  2007-01-29       Impact factor: 4.430

10.  MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts.

Authors:  R S Boyd; F R Balkwill
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.